target audience: TECH BUYER Publication date: Oct 2021 - Document type: IDC FutureScape - Doc Document number: # US48292121
IDC FutureScape: Worldwide Life Sciences 2022 Predictions
Table of Contents
-
IDC FutureScape Figure
-
Figure: IDC FutureScape: Worldwide Life Sciences 2022 Top 10 Predictions
-
-
Executive Summary
-
IDC FutureScape Predictions
-
Summary of External Drivers
-
Predictions: Impact on Technology Buyers
-
Prediction 1: By 2023, 75% of Life Sciences Manufacturers Will Invest in Intelligent Supply Chain Solutions to Enable Resilience and Prevent Future Disruptions During Health Emergencies Such as COVID-19
-
Associated Drivers
-
IT Impact
-
Patient Impact
-
Guidance
-
Prediction 2: By 2024, AI Investments in In Silico Drug Discovery Will Double to Fuel Growth of Genomics and Precision Medicine to Bring Vital Vaccines and Medicines to Patients Faster
-
Associated Drivers
-
IT Impact
-
Patient Impact
-
Guidance
-
Prediction 3: By 2025, 75% of Trials Will Be Patient-Centric Decentralized Clinical Trials; 90% Will Be Hybrid and at Least 10% Will Be Virtual, Driven by 30% Growth in Connected Health Technologies
-
Associated Drivers
-
IT Impact
-
Patient Impact
-
Guidance
-
Prediction 4: By 2025, the Market for Prescription Digital Therapeutics Will More Than Triple, Led by Mental Health and Chronic Conditions, Blurring the Boundaries Between Healthcare and Life Sciences
-
Associated Drivers
-
IT Impact
-
Patient Impact
-
Guidance
-
Prediction 5: Investment in AI for Real-World Evidence by Life Sciences Companies Will Double by 2025, Driven by Health Data Interoperability Initiatives and Platforms
-
Associated Drivers
-
IT Impact
-
Patient Impact
-
Guidance
-
Prediction 6: By 2026, Two-Thirds of Life Sciences Companies Will Adopt the Intelligent Lab of the Future Leveraging Digital Transformation, Integrating the Internet of Lab Things
-
Associated Drivers
-
IT Impact
-
Patient Impact
-
Guidance
-
Prediction 7: By 2026, the Increased Adoption of Medication Adherence Apps, Smart IoT–Based Solutions, and Connected Drug Delivery Systems Will Reduce Treatment Compliance Gaps in Clinical Trials by One-Third
-
Associated Drivers
-
IT Impact
-
Patient Impact
-
Guidance
-
Prediction 8: The Use of Digital Twins in Manufacturing and Supply Chain Planning at Multinational Life Sciences Firms Will Double by 2026, with Deeper Adoption in R&D Coming Later
-
Associated Drivers
-
IT Impact
-
Patient Impact
-
Guidance
-
Prediction 9: Triggered by COVID-19, Half of New Business Value Created in the Global Life Sciences Market by 2026 Will Be Driven by Cloud-Based Digital Ecosystems and Federated Learning, Powering R&D Co-Innovation
-
Associated Drivers
-
IT Impact
-
Patient Impact
-
Guidance
-
Prediction 10: Integrated Research Organizations Will Double in Number by 2027, Fueling the Adoption of Clinical Research as a Care Option Within the Healthcare Ecosystem
-
Associated Drivers
-
IT Impact
-
Patient Impact
-
Guidance
-
-
Advice for Technology Buyers
-
External Drivers: Detail
-
Pervasive Disruption Continues — Volatility, Opportunity, and Resilience
-
Cybersecurity and Risk — The Threat Environment Just Keeps Scaling
-
The Future Enterprise — Thriving in a Jungle of Agile Innovation
-
Embracing Digital First — New Strategies for Complexity and Ubiquity
-
Digital Ecosystem — Thriving in a Multiplatform World
-
Workforce Outlook — Redefining Teams, Reinventing Models, and Rethinking Leadership
-
Engagement Reimagined — From Responsive to Anticipatory
-
-
Learn More
-
Related Research
-